Does ERDAFITINIB Cause Hyperphosphataemia? 39 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 39 reports of Hyperphosphataemia have been filed in association with ERDAFITINIB (BALVERSA). This represents 3.5% of all adverse event reports for ERDAFITINIB.
39
Reports of Hyperphosphataemia with ERDAFITINIB
3.5%
of all ERDAFITINIB reports
4
Deaths
11
Hospitalizations
How Dangerous Is Hyperphosphataemia From ERDAFITINIB?
Of the 39 reports, 4 (10.3%) resulted in death, 11 (28.2%) required hospitalization, and 1 (2.6%) were considered life-threatening.
Is Hyperphosphataemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ERDAFITINIB. However, 39 reports have been filed with the FAERS database.
What Other Side Effects Does ERDAFITINIB Cause?
Death (255)
Off label use (86)
Diarrhoea (75)
Stomatitis (58)
Fatigue (45)
Onycholysis (44)
Disease progression (41)
Dry mouth (41)
Nail disorder (40)
Dry eye (38)
What Other Drugs Cause Hyperphosphataemia?
ALLOPURINOL (139)
LANSOPRAZOLE (138)
ACETAMINOPHEN (132)
SEVELAMER (129)
ONDANSETRON (127)
CALCITRIOL (125)
IPRATROPIUM (123)
ALBUTEROL (122)
METRONIDAZOLE (120)
HYDROMORPHONE (118)
Which ERDAFITINIB Alternatives Have Lower Hyperphosphataemia Risk?
ERDAFITINIB vs ERENUMAB
ERDAFITINIB vs ERENUMAB-AOOE
ERDAFITINIB vs ERENUMAB\ERENUMAB-AOOE
ERDAFITINIB vs ERGOCALCIFEROL
ERDAFITINIB vs ERGOCALCIFEROL\PHYTONADIONE\RETINOL\TOCOPHEROL